Evaluation of SHP1-P2 methylation as a biomarker of lymph node metastasis in patients with squamous cell carcinoma of the head and neck

[1]Manikantan K, Dwivedi RC, Sayed SI, Pathak KA, Kazi R. Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl. 2012; 93:576–82.ManikantanKDwivediRCSayedSIPathakKAKaziRCurrent concepts of surveillance and its significance in head and neck cancerAnn R Coll Surg Engl2012935768210.1308/003588411X604794356668022041231Search in Google Scholar

[2]Zhang X, Hunt JL, Shin DM, Chen ZG. Down-regulation of S100A2 in lymph node metastases of head and neck cancer. Head Neck. 2007; 29:236–43.ZhangXHuntJLShinDMChenZGDown-regulation of S100A2 in lymph node metastases of head and neck cancerHead Neck2007292364310.1002/hed.2051117123307Search in Google Scholar

[3]Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg. 2002; 235:133–9.GuCDOsakiTOyamaTInoueMKodateMDobashiKet alDetection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and SurvivalAnn Surg2002235133910.1097/00000658-200201000-00017142240511753052Search in Google Scholar

[4]Coello MC, Luketich JD, Litle VR, Godfrey TE. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer. 2004; 5:214–25.CoelloMCLuketichJDLitleVRGodfreyTEPrognostic significance of micrometastasis in non-small-cell lung cancerClin Lung Cancer200452142510.3816/CLC.2004.n.00214967073Search in Google Scholar

[5]Imoto S, Ochiai A, Okumura C, Wada N, Hasebe T. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol. 2006; 32:1175–9.ImotoSOchiaiAOkumuraCWadaNHasebeTImpact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical stainingEur J Surg Oncol2006321175910.1016/j.ejso.2006.08.00616979316Search in Google Scholar

[6]Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol. 2011; 18:2732–8.BroglieMAHaileSRStoeckliSJLong-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinomaAnn Surg Oncol2011182732810.1245/s10434-011-1780-621594704Search in Google Scholar

[7]Rahbari NN, Bork U, Motschall E, Thorlund K, Büchler MW, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30:60–70.RahbariNNBorkUMotschallEThorlundKBüchlerMWKochMWeitzJMolecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysisJ Clin Oncol201230607010.1200/JCO.2011.36.950422124103Search in Google Scholar

[8]Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, Hirankarn N, Mutirangura A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med (Berl). 2006; 84:175–82.RuchusatsawatKWongpiyabovornJShuangshotiSHirankarnNMutiranguraASHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasisJ Mol Med (Berl)2006841758210.1007/s00109-005-0020-616389548Search in Google Scholar

[9]Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol. 2011; 6:1818–25.VinayanuwattikunCSriuranpongVTanasanvimonSChantranuwatPMutiranguraAEpithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancerJ Thorac Oncol2011618182510.1097/JTO.0b013e318226b46f21964525Search in Google Scholar

[10]Vinayanuwattikun C, Mingmalairak S, Jittapiromsak N, Thaipisuttikul I, Sriuranpong V, Mutirangura A, Shuangshoti S. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis). J Neurooncol. 2016; 129:395–403.VinayanuwattikunCMingmalairakSJittapiromsakNThaipisuttikulISriuranpongVMutiranguraAShuangshotiSSHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis)J Neurooncol201612939540310.1007/s11060-016-2199-527401153Search in Google Scholar

[11]Vinayanuwattikun C, Chantranuwat P, Sriuranpong V, Mutirangura A. The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence. Int J Clin Oncol. 2014; 19:586–92.VinayanuwattikunCChantranuwatPSriuranpongVMutiranguraAThe role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrenceInt J Clin Oncol2014195869210.1007/s10147-013-0605-ySearch in Google Scholar

[12]Rattanatanyong P, Keelawat S, Kitkumthorn N, Mutirangura A. Epithelial-specific SHP1-P2 methylation - a novel universal tumor marker for detection of colorectal cancer lymph node metastasis. Asian Pac J Cancer Prev. 2016; 17:4117–23.RattanatanyongPKeelawatSKitkumthornNMutiranguraAEpithelial-specific SHP1-P2 methylation - a novel universal tumor marker for detection of colorectal cancer lymph node metastasisAsian Pac J Cancer Prev201617411723Search in Google Scholar

[13]Kitkumthorn N, Mutirangura A. LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Oral Dis. 2010; 16:286–91.KitkumthornNMutiranguraALINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumorOral Dis2010162869110.1111/j.1601-0825.2009.01640.x20374511Search in Google Scholar

[14]Patel AN, Mehnert JM, Kim S. Treatment of recurrent metastatic head and neck cancer: focus on cetuximab. Clin Med Insights Ear Nose Throat. 2012; 5:1–16.PatelANMehnertJMKimSTreatment of recurrent metastatic head and neck cancer: focus on cetuximabClin Med Insights Ear Nose Throat2012511610.4137/CMENT.S5129379194924179404Search in Google Scholar

[15]Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg. 2001; 88:1307–20.TsavellasGPatelHAllen-MershTGDetection and clinical significance of occult tumour cells in colorectal cancerBr J Surg20018813072010.1046/j.0007-1323.2001.01863.x11578283Search in Google Scholar

[16]Riethdorf S, Wikman H, Pantel K. Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008; 123:1991–2006.RiethdorfSWikmanHPantelKReview: Biological relevance of disseminated tumor cells in cancer patientsInt J Cancer20081231991200610.1002/ijc.2382518712708Search in Google Scholar

[17]Wada N, Imoto S. Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol. 2008; 13:24–32.WadaNImotoSClinical evidence of breast cancer micrometastasis in the era of sentinel node biopsyInt J Clin Oncol200813243210.1007/s10147-007-0736-018307016Search in Google Scholar

[18]Shimizu Y, Takeuchi H, Sakakura Y, Saikawa Y, Nakahara T, Mukai M, et al. Molecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assay. Ann Surg Oncol. 2012; 19:469–77.ShimizuYTakeuchiHSakakuraYSaikawaYNakaharaTMukaiMet alMolecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assayAnn Surg Oncol2012194697710.1245/s10434-011-2122-422065193Search in Google Scholar

[19]Patel V, Martin D, Malhotra R, Marsh CA, Doçi CL, Veenstra TD, et al. DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays. Oral Oncol. 2013; 49:93–101.PatelVMartinDMalhotraRMarshCADoçiCLVeenstraTDet alDSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarraysOral Oncol2013499310110.1016/j.oraloncology.2012.08.001354615823010602Search in Google Scholar

[20]Barrera JE, Miller ME, Said S, Jafek BW, Campana JP, Shroyer KR. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope. 2003; 113:892–6.BarreraJEMillerMESaidSJafekBWCampanaJPShroyerKRDetection of occult cervical micrometastases in patients with head and neck squamous cell cancerLaryngoscope2003113892610.1097/00005537-200305000-0002212792329Search in Google Scholar

[21]Kitkumthorn N, Keelawat S, Rattanatanyong P, Mutirangura A. LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers. Asian Pac J Cancer Prev. 2012; 13:4469–75.KitkumthornNKeelawatSRattanatanyongPMutiranguraALINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancersAsian Pac J Cancer Prev20121344697510.7314/APJCP.2012.13.9.446923167363Search in Google Scholar

[22]Kitkumthorn N, Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clinical Epigenetics. 2011; 2:315.KitkumthornNMutiranguraALong interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applicationsClinical Epigenetics2011231510.1007/s13148-011-0032-8336538822704344Search in Google Scholar

[23]Chujan S, Kitkumthorn N, Siriangkul S, Mutirangura A. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions. Asian Pac J Cancer Prev. 2014; 15:7971–5.ChujanSKitkumthornNSiriangkulSMutiranguraACCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesionsAsian Pac J Cancer Prev2014157971510.7314/APJCP.2014.15.18.7971Search in Google Scholar